Journal of Drugs in Dermatology

Overview on desonide 0.05%: a clinical safety profile.(ARTICLES)

Journal of Drugs in Dermatology | July 1, 2004 | Copyright

Abstract

Desonide (as a cream, ointment, or lotion formulation) is widely used for the treatment of steroid-responsive dermatoses. This paper provides information on its safety record, as determined from adverse event reports and published trial results. A pharmacovigilance program, initiated in 1992 for all countries where desonide is available, collected reports of adverse events associated with topical desonide over nine years. Published accounts of randomized, controlled trials of desonide in comparison with hydrocortisone were reviewed. Sixty-two reports have been…

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Overview on desonide 0.05%: a clinical safety profile.(ARTICLES)
Magazine article from: Journal of Drugs in Dermatology ...formulation and safety profile and, finally...paper reviews the safety profile of topical desonide, a mild to moderately...Surveillance of Safety A global post...include published clinical trials where desonide...preparation of desonide 0.05% known ...

For more facts and information, see all results

Find more facts and information related to the article Overview on desonide 0.05%: a clinical safety ...